JPMorgan Starts Seres Therapeutics (MCRB) at Neutral
Tweet Send to a Friend
(Updated - April 21, 2023 4:16 AM EDT)
JPMorgan analyst Tessa Romero initiates coverage on Seres Therapeutics (NASDAQ: MCRB) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Tessa Romero initiates coverage on Seres Therapeutics (NASDAQ: MCRB) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


